课题基金 / 基金详情

MOLECULAR MECHANISMS OF DIAZEPAM TOLERANCE

MOLECULAR MECHANISMS OF DIAZEPAM TOLERANCE
地西泮耐受性的分子机制
批准号:
2858049
负责人:
ERMINIO COSTA
金额:
$9.22万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-01-01 至 2000-12-31

项目摘要

项目成果

ERMINIO COSTA的其他基金

相似基金

相关文献

中文摘要
翻译
描述(改编自申请人摘要):对
英文摘要
DESCRIPTION (Adapted from applicant's abstract): Tolerance to benzodiazepines (BZ) limits their clinical use of anticonvulsants, anxiolytic and antipanic agents. In the clinical practice to maintain the level of drug efficacy the BZ doses are increased to overcome tolerance and this often leads to physical dependence. We must understand the mechanisms of BZ tolerance in order to overcome the problems in their clinical use and we believe that this will also bring about an initial understanding of how GABAergic transmission is regulated. BZ can be classified as FULL or PARTIAL allosteric modulators of GABA action at GABA-a receptors (FAM and PAM, respectively). Both drug classes act on GABA-a receptors that include one alpha1-5 and one gamma2-3 subunit in their structure, but their intrinsic activity in amplifying GABA action differs. Diazepam, (a FAM), but not imidazenil, (a PAM) induces tolerance in rodents. In preliminary studies, we have shown that in tolerance rats there is a change in the expression of mRNAs encoding for alpha1, gamma2 and alpha5 GABA-a receptor subunits which reverses when tolerance is reversed. Such changes are not present in rats receiving imidazenil in doses equipotent to those of diazepam that induce tolerance. These two drugs will be used as research tools to explore the mechanism of diazepam tolerance. We hypothesize that tolerance to diazepam is triggered by an alteration of GABA-a receptor subunit expression restricted to functionally dedicated brain areas. We propose a systematic investigation of the mechanism of diazepam tolerance in rats with the following aims: (1) Determine onset and duration of diazepam tolerance to its anticonvulsant, anticonflict and cognition disrupting action using as a contrast imidazemil, (2) PCR analysis changes in 14 subunit mRNA content in 28 brain areas at the onset and termination of diazepam tolerance and test whether imidazenil produces similar changes or antagonizes diazepam changes, (3) Measure with gold immunolabeling in brain slices the content of 8 different GABA-a receptor subunits in pertinent brain areas of diazepam tolerant rats using imidazenil as a contrast and/or as antagonist and (4) Study changes of subunit expression in neuronal membranes of dissociated cultures prepared from pertinent brain areas of tolerant rats; determine receptor coexpression of pertinent subunits with double-immunolabelling with gold particles of different size.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
On the putative physiological role of allopregnanolone on GABA(A) receptor function.
关于四氢孕酮对 GABA(A) 受体功能的假定生理作用。
DOI: 10.1016/s0028-3908(02)00341-6
发表时间: 2003
期刊: Neuropharmacology
影响因子: 4.7
作者: [Puia,G, Mienville,J-M, Matsumoto,K, Takahata,H, Watanabe,H, Costa,E, Guidotti,A]
通讯作者: Guidotti,A
Imidazenil, a positive allosteric GABAA receptor modulator, inhibits the effects of cocaine on locomotor activity and extracellular dopamine in the nucleus accumbens shell without tolerance liability.
咪达西尼是一种正向变构 GABAA 受体调节剂,可抑制可卡因对伏隔核壳中运动活性和细胞外多巴胺的影响,且无耐受性。
DOI: --
发表时间: 1998
期刊: The Journal of pharmacology and experimental therapeutics
影响因子: --
作者: [Giorgetti,M, Javaid,JI, Davis,JM, Costa,E, Guidotti,A, Appel,SB, Brodie,MS]
通讯作者: Brodie,MS
GABAergic molecular pathology in schizophrenia
GABAergic molecular pathology in schizophrenia
GABAergic molecular pathology in schizophrenia
GABAergic molecular pathology in schizophrenia
海外基金